You are here

Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Tower
Seoul, , 04631 Korea, Republic of
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Advanced Renal Cell Carcinoma
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients diagnosed as advanced RCC after failure of one prior systemic therapy.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any patient who does not agree that Pfizer or companies working on behalf of Pfizer
can use his/her information.

- Patients with hypersensitivity to axitinib or to any other component of INLYTA® .

- Patients under 18.

- Pregnant women.

NCT02156895
Pfizer
Recruiting
Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Advanced Renal Cell Carcinoma
NCT02156895
All Genders
18+
Years
Seoul,

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now